A decrease in STAT1 and STAT3 mRNA expression after in vitro culture with media in IFNb-treated MS and not in HC and untreated MS was associated to their increased expression in all groups after IL-27 in vitro exposure, which confirms our results and is in accordance with the literature (Figure 5D) [21]. The gene discussed is STAT3; the disease is myeloid sarcoma.